TY  - JOUR
AU  - Martin-Broto, Javier
AU  - Hindi, Nadia
AU  - Lopez-Pousa, Antonio
AU  - Peinado-Serrano, Javier
AU  - Alvarez, Rosa
AU  - Alvarez-Gonzalez, Ana
AU  - Italiano, Antoine
AU  - Sargos, Paul
AU  - Cruz-Jurado, Josefina
AU  - Isern-Verdum, Josep
AU  - Dolado, Maria Carmen
AU  - Rincon-Perez, Inmaculada
AU  - Sanchez-Bustos, Paloma
AU  - Gutierrez, Antonio
AU  - Romagosa, Cleofe
AU  - Morosi, Carlo
AU  - Grignani, Giovanni
AU  - Gatti, Marco
AU  - Luna, Pablo
AU  - Alastuey, Ignacio
AU  - Redondo, Andres
AU  - Belinchon, Belen
AU  - Martinez-Serra, Jordi
AU  - Sunyach, Marie-Pierre
AU  - Coindre, Jean-Michel
AU  - Dei Tos, Angelo P
AU  - Romero, Jesus
AU  - Gronchi, Alessandro
AU  - Blay, Jean-Yves
AU  - Moura, David S
PY  - 2020
DO  - 10.1001/jamaoncol.2019.6584
UR  - http://hdl.handle.net/10668/15136
T2  - JAMA oncology
AB  - Active therapeutic combinations, such as trabectedin and radiotherapy, offer potentially higher dimensional response in second-line treatment of advanced soft-tissue sarcomas. Dimensional response can be relevant both for symptom relief and for...
LA  - en
PB  - American Medical Association
KW  - Combined Modality Therapy
KW  - Dose-Response Relationship, Radiation
KW  - Humans
KW  - Middle Aged
KW  - Spain
KW  - Trabectedin
KW  - Adult
KW  - Aged
KW  - Disease-Free Survival
KW  - Dose-Response Relationship, Drug
KW  - Female
KW  - France
KW  - Italy
KW  - Male
KW  - Neoplasm Metastasis
KW  - Sarcoma
KW  - Spain
TI  - Assessment of Safety and Efficacy of Combined Trabectedin and Low-Dose Radiotherapy for Patients With Metastatic Soft-Tissue Sarcomas: A Nonrandomized Phase 1/2 Clinical Trial.
TY  - research article
VL  - 6
ER  -